Levofloxacin hydrate CAS No.138199-71-0 / Cat No.EBD48313
(S)-(-)-Ofloxacine
(-)-(s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hydrochloride
Levofloxacin hemihydrate
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrate
(-)-(s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hydrochloride
Levofloxacin hemihydrate
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrate
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate (2:1)
Levofloxacin hydrate
levofloxacin hcl
levofloxacinh hydrochloride
(s)-(-)-ofloxacine
levofloxacine
Properties
-
Appearance:
pale yellow solid
-
Density:
1.48 g/cm3
-
Melting point:
214-216°C
-
Boiling point:
571.5 °C at 760 mmHg
-
Flashing point:
299.4 °C
Safety Information
-
Symbol:
-
Signal words:
Danger -
Hazard statements:
H302 Harmful if swallowed.
H317 May cause an allergic skin reaction.
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
H361d Suspected of damaging the unborn child.
H362 May cause harm to breast-fed children.
-
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P263 Avoid contact during pregnancy/while nursing.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P342+P311 IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
NMR Spectrum
1H NMR
13C NMR
